5T3W | pdb_00005t3w

Marburg virus VP30 bound to nucleoprotein


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.25 Å
  • R-Value Free: 
    0.241 (Depositor), 0.235 (DCC) 
  • R-Value Work: 
    0.213 (Depositor), 0.206 (DCC) 
  • R-Value Observed: 
    0.214 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 5T3W

This is version 1.4 of the entry. See complete history

Literature

The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis.

Kirchdoerfer, R.N.Moyer, C.L.Abelson, D.M.Saphire, E.O.

(2016) PLoS Pathog 12: e1005937-e1005937

  • DOI: https://doi.org/10.1371/journal.ppat.1005937
  • Primary Citation Related Structures: 
    5T3T, 5T3W

  • PubMed Abstract: 

    Filoviruses are capable of causing deadly hemorrhagic fevers. All nonsegmented negative-sense RNA-virus nucleocapsids are composed of a nucleoprotein (NP), a phosphoprotein (VP35) and a polymerase (L). However, the VP30 RNA-synthesis co-factor is unique to the filoviruses. The assembly, structure, and function of the filovirus RNA replication complex remain unclear. Here, we have characterized the interactions of Ebola, Sudan and Marburg virus VP30 with NP using in vitro biochemistry, structural biology and cell-based mini-replicon assays. We have found that the VP30 C-terminal domain interacts with a short peptide in the C-terminal region of NP. Further, we have solved crystal structures of the VP30-NP complex for both Ebola and Marburg viruses. These structures reveal that a conserved, proline-rich NP peptide binds a shallow hydrophobic cleft on the VP30 C-terminal domain. Structure-guided Ebola virus VP30 mutants have altered affinities for the NP peptide. Correlation of these VP30-NP affinities with the activity for each of these mutants in a cell-based mini-replicon assay suggests that the VP30-NP interaction plays both essential and inhibitory roles in Ebola virus RNA synthesis.


  • Organizational Affiliation
    • Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California, United States of America.

Macromolecule Content 

  • Total Structure Weight: 161.36 kDa 
  • Atom Count: 8,624 
  • Modeled Residue Count: 1,096 
  • Deposited Residue Count: 1,432 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Fusion protein of Nucleoprotein and Minor nucleoprotein VP30
A, B, C, D, E
A, B, C, D, E, F, G, H
179Marburg virus - Musoke, Kenya, 1980Mutation(s): 0 
Gene Names: NPVP30
UniProt
Find proteins for P27588 (Lake Victoria marburgvirus (strain Musoke-80))
Explore P27588 
Go to UniProtKB:  P27588
Find proteins for P35258 (Lake Victoria marburgvirus (strain Musoke-80))
Explore P35258 
Go to UniProtKB:  P35258
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupsP35258P27588
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.25 Å
  • R-Value Free:  0.241 (Depositor), 0.235 (DCC) 
  • R-Value Work:  0.213 (Depositor), 0.206 (DCC) 
  • R-Value Observed: 0.214 (Depositor) 
Space Group: P 31 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 106.143α = 90
b = 106.143β = 90
c = 375.573γ = 120
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
XDSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesR01 AI118016

Revision History  (Full details and data files)

  • Version 1.0: 2016-09-28
    Type: Initial release
  • Version 1.1: 2016-11-02
    Changes: Database references
  • Version 1.2: 2017-09-27
    Changes: Author supporting evidence, Derived calculations
  • Version 1.3: 2019-12-11
    Changes: Author supporting evidence
  • Version 1.4: 2023-10-04
    Changes: Data collection, Database references, Refinement description